OTC · Healthcare
MARIMED INC. (MRMD)
As-reported financials and recent SEC filings for MARIMED INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$159.8M
Net income
$-14.5M
Net margin
-9.1%
Diluted EPS
$-0.04
ROE
-29.0%
P/E (TTM)
—
Market cap
—
Debt / equity
1.5×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $159.8M | $157.7M | $148.6M | $134.0M | $121.5M |
| Gross profit | $57.9M | $62.6M | $65.9M | $64.0M | $66.3M |
| Operating income | $-2.8M | $2.6M | $14.4M | $20.4M | $26.9M |
| Net income | $-14.5M | $-12.5M | $-16.0M | $13.5M | $7.2M |
| Diluted EPS | $-0.04 | $-0.03 | $-0.04 | $0.04 | $0.02 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-16
View on EDGAR →42026-06-12
View on EDGAR →42026-06-12
View on EDGAR →42026-06-12
View on EDGAR →42026-06-08
View on EDGAR →42026-06-08
View on EDGAR →42026-06-08
View on EDGAR →42026-06-08
View on EDGAR →Largest Healthcare peers
Go deeper on MRMD
Search MARIMED INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.